3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Interventions
fludarabine
33
Specimen Handling
32
Azacitidine
30
venetoclax
29
Cyclophosphamide
29
Biopsy
25
fludarabine phosphate
23
Whole-Body Irradiation
19
Cytarabine
19
ruxolitinib
18
Mycophenolic Acid
18
Busulfan
18
Tacrolimus
16
asciminib
15
Melphalan
14
Injections
14
Decitabine
14
X-Rays
12
Stem Cell Transplantation
12
Granulocyte Colony-Stimulating Factor
12
decitabine and cedazuridine drug combination
11
Magnetic Resonance Spectroscopy
11
Cyclosporine
11
Sirolimus
10
Peripheral Blood Stem Cell Transplantation
10
Thiotepa
9
Filgrastim
9
nilotinib
7
Methotrexate
7
Imatinib Mesylate
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
N(4)-oleylcytosine arabinoside
×
Myeloid
×
90 days
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled